Alphatec Holdings, Inc. Product Pipeline Analysis

SUMMARY

Alphatec Holdings, Inc. Product Pipeline Analysis

Summary

This report is an insightful source for data, analysis and strategic insights into a Alphatec Holdings, Inc.'s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

• Details of development stage by sector and equipment type.
• Pipeline products grouped by therapy area, development stage and trial phase.
• Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
• Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
• Product updates covering estimated approval dates and estimated launch dates.
• Descriptions of novel technologies relating to pipeline products of the company.
• Patents and patent applications covered for the product.
• News updates on key events relating to the product and its development.

Reasons to buy

• A single source to fulfill competitor information relating to products in development.
• Identify pipeline products that are potential competitor to your product lines.
Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.
• Access clinical trial information to map trial results and plan targeted marketing activities.
• Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
• Identification of potential investment opportunities.
• Build up knowledge base for potential distribution and marketing partners.
• Helps avoid patent infringement.
• Timelines from concept to market lets you keep track of market potential build for a new product.
Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

TABLE OF CONTENTS

1 Table of Contents 3
1.1 List Of Tables 6
1.2 List of Figures 7
2 Company Overview 8
2.1 Key Information 8
2.2 Financial Performance 8
2.3 Industry Outlook -- Orthopedic Devices 8
3 Major Products and Services 9
3.1 Overview 9
4 Competitors 10
5 Key Employees 11
6 Locations And Subsidiaries 12
6.1 Head Office 12
7 Recent Developments 13
7.1 Financial Announcements 13
7.1.1 Jul 30, 2008: Alphatec To Declare 2Q 2008 Results 13
7.1.2 Apr 24, 2008: Alphatec Reports Q1 2008 Results 13
7.1.3 Feb 13, 2008: Alphatec Reports Q4 Results 2007 15
7.1.4 Oct 23, 2007: Alphatec Reports Q3 Results 2007 16
7.1.5 Aug 06, 2007: Alphatec Reports Q2 Results 2007 17
7.1.6 Apr 26, 2007: Alphatec Reports Q1 Results 2007 18
7.2 Corporate Communications 19
7.2.1 May 09, 2008: Alphatec CFO To Resign 19
7.2.2 Apr 03, 2008: Alphatec Appoints President For API 20
7.2.3 Apr 02, 2008: Alphatec Appoints Vice President, Corporate Accounts 20
7.2.4 Feb 11, 2008: Alphatec Appoints Vice President, Research And Development 20
7.2.5 Feb 05, 2008: Alphatec Elects Board Of Directors 21
7.2.6 Jul 20, 2007: Alphatec Appoints Chairman 21
7.2.7 Jun 28, 2007: Alphatec Appoints New SAB Member 21
7.2.8 Jun 06, 2007: Alphatec Appoints New CEO 22
7.3 Product News 22
7.3.1 Apr 24, 2008: Alphatec Holdings, Inc. Terminates License For DYNAMO Semi Rigid Rod System 22
7.3.2 Jan 16, 2008: Alphatec Holdings, Inc. Announces The Commercial Introduction Of Its Unique DYNAMO Semi-Rigid Spinal System 23
7.3.3 Nov 19, 2007: Alphatec Holdings, Inc. Receives FDA 510(k) Clearance For The ZODIAC LUXE 4.0 Millimeter Diameter Pedicle Screw 23
7.3.4 Oct 25, 2007: Alphatec Holdings, Inc. Receives FDA 510(k) Clearance For the DYNAMO Rod System 23
7.3.5 Sep 13, 2007: Alphatec Holdings, Inc Acquires An Exclusive Worldwide License For Technology Related To Guided Lumbar Interbody Fusion System 24
7.3.6 Sep 12, 2007: Alphatec Holdings, Inc. Acquires An Exclusive Worldwide License For Vertebroplasty Technology System Focused On Solutions For Vertebral Compression Fractures 24
7.3.7 Jul 06, 2006: Alphatec Holdings, Inc. Announces Exclusive Licensing Agreement For Dynamic Cervical Plate System 25
7.4 Product Approvals 25
7.4.1 Nov 19, 2007: Alphatec Holdings, Inc. Receives FDA 510(k) Clearance For The ZODIAC LUXE 4.0 Millimeter Diameter Pedicle Screw 25
8 Alphatec Holdings, Inc. Pipeline Products 26
8.1 Alphatec Holdings, Inc. Product Pipeline Analysis 26
8.1.1 Alphatec Holdings, Inc. Pipeline Products By Equipment Type 26
8.1.2 Alphatec Holdings, Inc. Pipeline Products By Development Stage 27
8.1.3 Alphatec Holdings, Inc. Pipeline Products By Therapy Area 28
8.1.4 Alphatec Holdings, Inc. Pipeline Products By Clinical Trials 28
8.1.5 Alphatec Holdings, Inc. Pipeline Products By News Summary 28
8.2 Dynamic Cervical Plate 28
8.2.1 Product Description 29
8.2.2 Product Status 29
8.2.3 Product Milestone 29
8.3 Anterior Lumbar Interbody Fusion (ALIF) Plate System 29
8.3.1 Product Description 30
8.3.2 Product Status 30
8.4 JGMG Guided Lumbar Interbody Fusion System 30
8.4.1 Product Description 30
8.4.2 Product Status 30
8.4.3 Product Milestone 31
8.5 Solanas Posterior Occipital Plate 31
8.5.1 Product Description 31
8.5.2 Product Status 31
8.6 ZODIAC Minimally Invasive System (MIS) 32
8.6.1 Product Description 32
8.6.2 Product Status 32
8.7 V-Stent 32
8.7.1 Product Description 32
8.7.2 Product Status 32
8.7.3 Product Milestone 33
8.8 OsseoFix 33
8.8.1 Product Description 34
8.8.2 Product Status 34
8.8.3 Clinical Trials 34
8.8.4 Product Milestone 34
9 Appendix 36
9.1 Methodology 36
9.1.1 Coverage 36
9.1.2 Secondary Research 37
9.1.3 Primary Research 37
9.1.4 Expert Panel Validation 38
9.2 Contact Us 38
9.3 About Global Markets Direct 38
9.4 Disclaimer 38

1.1 List of Tables
Table 1: Alphatec Holdings, Inc.,Key Facts 8
Table 2: Alphatec Holdings, Inc., Key Employees, 11
Table 3: Alphatec Holdings, Inc. Pipeline Products by Equipment Type 26
Table 4: Alphatec Holdings, Inc. Pipeline Products By Development Stage 27
Table 5: Alphatec Holdings, Inc. Pipeline Products By Therapy Area 28
Table 6: Alphatec Holdings, Inc. Pipeline Products By Clinical Trials 28
Table 7: Alphatec Holdings, Inc. Pipeline Products By News Summaries 28

1.2 List of Figures
Figure 1: Alphatec Holdings, Inc. Pipeline Products By Development Stage 27
Figure 2: Global Markets Direct Methodology 36